    <SEC-DOCUMENT>0001764013-26-000093-index.html : 20260722
    <SEC-HEADER>0001764013-26-000093.hdr.sgml : 20260722
    <ACCEPTANCE-DATETIME>20260722161320
    ACCESSION NUMBER:		0001764013-26-000093
    CONFORMED SUBMISSION TYPE:	DEFA14A
    PUBLIC DOCUMENT COUNT:		3
    FILED AS OF DATE:		20260722
    DATE AS OF CHANGE:		20260722

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Immunovant, Inc.
    		CENTRAL INDEX KEY:			0001764013
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				832771572
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			0331

    	FILING VALUES:
    		FORM TYPE:		DEFA14A
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-38906
    		FILM NUMBER:		261193829

    	BUSINESS ADDRESS:
    		STREET 1:		1000 PARK FORTY PLAZA
    		CITY:			DURHAM
    		STATE:			NC
    		ZIP:			27713
    		BUSINESS PHONE:		917-410-3120

    	MAIL ADDRESS:
    		STREET 1:		1000 PARK FORTY PLAZA
    		CITY:			DURHAM
    		STATE:			NC
    		ZIP:			27713

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Health Sciences Acquisitions Corp
    		DATE OF NAME CHANGE:	20190108
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>DEFA14A
    <SEQUENCE>1
    <FILENAME>defa14aadditionalmaterials.htm
    <DESCRIPTION>DEFA14A
    <TEXT>
    Document 1 - file: defa14aadditionalmaterials.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>2
    <FILENAME>immunovantinc_vxnoticeanda.jpg
    <TEXT>
    Document 2 - file: immunovantinc_vxnoticeanda.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>immunovantinc_vxnoticeandaa.jpg
    <TEXT>
    Document 3 - file: immunovantinc_vxnoticeandaa.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>